Risk factors for hepatitis C virus transmission in colonial Cameroon

Clinical Infectious Diseases

Volumn 51, Issue 7, 2010, Pages 768-776

  Pépin, Jacques ^a   Lavoie, Myriam ^a   Pybus, Oliver G ^c   Pouillot, Régis ^d   Foupouapouognigni, Yacouba ^d   Rousset, Dominique ^d   Labbé, Annie Claude ^b   Njouom, Richard ^d  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d CENTRE PASTEUR DU CAMEROUN   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; VIRUS ANTIBODY;

ADULT; AGE; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD TRANSFUSION; CAMEROON; CIRCUMCISION; CROSS-SECTIONAL STUDY; FEMALE; GENE SEQUENCE; GENOTYPE; GROWTH; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MAJOR CLINICAL STUDY; MALARIA; MALE; MOLECULAR CLOCK; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS GENE; VIRUS TRANSMISSION;

AGED; AGED, 80 AND OVER; CAMEROON; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IATROGENIC DISEASE; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY;

EID: 77957853025     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/656233     Document Type: Article

References (32)

1. Frank C, Mohamed MK, Strickland G, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000; 355:887-891.
2. Madhava V, Burges C, Drucker E. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis 2002; 2:293-302.
3. Nkengasong J, de Beenhouwer H, Claeys H, et al. A pilot study of the prevalence of hepatitis C virus antibodies and hepatitis C virus RNA in southern Cameroon. Am J Trop Med Hyg 1995; 52:98-100.
4. Nerrienet E, Pouillot R, Lachenal G, et al. Hepatitis C virus infection in Cameroon: a cohort effect. J Med Virol 2005; 76:208-214.
5. Ndong-Atome G, Makuwa M, Ouwe-Missi-Oukem-Boyer O, et al. High prevalence of hepatitis C virus infection and predominance of genotype 4 in rural Gabon. J Med Virol 2008; 80:1581-1587.
6. Njouom R, Nerrienet E, Dubois M, et al. The hepatitis C virus epidemic in Cameroon: genetic evidence for rapid transmission between 1920 and 1960. Infect Genet Evol 2007; 7:361-367.
7. Njouom R, Frost E, Deslandes S, et al. Predominance of hepatitis C genotype 4 infection and rapid transmission between 1935 and 1965 in the Central African Republic. J Gen Virol 2009; 90:2452-2456.
8. Pépin J, Labbé AC. Noble goals, unforeseen consequences: the control of tropical diseases in colonial Central Africa and the iatrogenic transmission of blood-borne viruses Trop Med Int Health 2008; 13:744-753.
9. Worobey M, Gemmel M, Teuwen DE, et al. Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature 2008; 455:661-664.
10. Keele B, van Heuverswyn F, Li Y, et al. Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. Science 2006; 313:523-526.
11. Neel C, Etienne L, Li Y, et al. Molecular epidemiology of simian immunodeficiency virus infection in wild-living gorillas. J Virol 2010; 84:1464-1476.
12. Njouom R, Pasquier C, Ayouba A, et al. Hepatitis C virus infection among pregnant women in Yaoundé, Cameroon: prevalence, viremia and genotypes. J Med Virol 2003; 69:384-390.
13. Pasquier C, Njouom R, Ayouba A, et al. Distribution and heterogeneity of hepatitis C genotypes in hepatitis patients in Cameroon. J Med Virol 2005; 77:390-398.
14. Castelain S, Descamps V, Thibault V, et al. TaqMan amplification system with an internal positive control for HCV RNA quantitation. J Clin Virol 2004; 31:227-234.
15. Grebely J, Raffa J, Lai C, Krajden M, Tyndall M. Hepatitis C virus reinfection in injection drug users. Hepatology 2006; 44:1139-1145.
16. Amin J, Law MG, Bartlett M, Kaldor JM, Dore GJ. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet 2006; 368:938-945.
17. Yazdanpanah Y, De Carli G, Migueres B, et al. Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: a European case-control study. Clin Infect Dis 2005; 41:1423-1430.
18. Hay S, Guerra CA, Gething P, et al. A world malaria map: Plasmodium falciparum endemicity in 2007. PLoS Med 2009; 6:e1000048.
19. Vaucel M. Médecine tropicale. Paris: Flammarion, 1952.
20. Bertaut M. Le droit coutumier des Boulous: monographie d'une tribu du Sud-Cameroun. Paris: Loviton, 1935.
21. Medhat A, Shehata M, Magder L, et al. Hepatitis C in a community in Upper Egypt: risk factors for infection. Am J Trop Med Hyg 2002;66:633-638.
22. The Central Hospital: Elat, Ebolowa, West Africa. Ebolowa: West Africa Mission of the Presbyterian Church, 1935.
23. Schneider WH, Drucker E. Blood transfusions in the early years of AIDS in sub-Saharan Africa. Am J Public Health 2006; 96:984-994.
24. Blanchard M. Précis d'épidémiologie: médecine préventive et hygiène coloniale. Paris: Vigot Frères, 1938.
25. Plamondon M, Labbé AC, Frost E, et al. Hepatitis C virus infection in Guinea-Bissau: a sexually transmitted genotype 2 with parenteral amplification? PLOS One 2007; 2:e372.
26. Moudgil K, Irshad M. Global overview of the prevalence of hepatitis B virus markers (HBsAg and anti-HBs) in leprosy patients. Trop Gastroenterol 1988; 9:184-190.
27. Verdier M, Denis F, Sangaré A, et al. Antibodies to human T lymphotropic virus type 1 in patients with leprosy in tropical areas. J Infect Dis 1990; 161:1309-1310.
28. Moraes Braga AC, Reason I, Maluf E, et al. Leprosy and confinement due to leprosy show high association with hepatitis C in Southern Brazil. Acta Tropica 2006; 97:88-93.
29. Denis F, Aussel L, Ranger S, et al. Prevalence of antibodies to hepatitis C virus among patient with leprosy in several African countries and the Yemen. J Med Virol 1994; 43:1-4.
30. Pépin J, Labbé A-C, Mamadou-Yaya F, et al. Iatrogenic transmission of human T cell lymphotropic virus type 1 and hepatitis C virus through parenteral treatment and chemoprophylaxis of sleeping sickness in colonial Equatorial Africa. Clin Infect Dis 2010; 50(7):777-784 (in this issue).
31. Pépin J, Plamondon M, Alves AC, Beaudet M, Labbé AC. Parenteral transmission during excision and treatment of tuberculosis and trypanosomiasis may be responsible for the HIV-2 epidemic in Guinea-Bissau. AIDS 2006; 20:1303-1311.
32. Markov PV, Pepin J, Frost E, Deslandes S, Labbé AC, Pybus OG. The phylogeography and molecular epidemiology of hepatitis C virus genotype 2 in Africa. J Gen Virol 2009; 90:2086-2096.